TESARO to Present at Two Upcoming Investment Conferences

WALTHAM, Mass., Feb. 5, 2014 (GLOBE NEWSWIRE) -- TESARO, Inc. (Nasdaq: TSRO) announced today that Lonnie Moulder, CEO of TESARO, and Mary Lynne Hedley, Ph.D., President of TESARO, will participate in two investment conferences in February, including:

• The Leerink Swann Global Healthcare Conference at the Waldorf Astoria in New York City. TESARO will present at the conference on February 13, 2014 at 11:10 AM Eastern time. Live webcasts of this presentation will be accessible via the Investors page of the TESARO website at www.tesarobio.com. An archived replay of the webcasts will be available on the Company's website for 14 days following the conference.  
• The Citi 2014 Global Healthcare Conference at the Hilton New York in New York City. TESARO will participate in the "Hot Topics in Breast Cancer" panel at the conference on February 25, 2014 at 1:50 PM Eastern time.

About TESARO

TESARO, Inc. is an oncology-focused biopharmaceutical company dedicated to improving the lives of cancer patients.

CONTACT: For further information, please contact:
         Jennifer Davis
         Sr. Director, Corporate Development & Investor Relations
         1.781.325.1116
         [email protected]

You May Also Be Interested In

• Blockmate Closes Oversubscribed $1.0 Million Private Placement and Announces Toronto Investor Roadshow
• Xtract One Technologies Further Expands Into Pharmaceutical and Life Sciences Manufacturing With New Multi-State Deployment
• Ironwood Appoints Dr. Jeffrey Silber Chief Medical Officer and Head of Research and Drug Development; STARS-2 Trial Initiated in June and Is Now Actively Recruiting Patients